Contribution of pancreatic α-cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes

J Diabetes Investig. 2019 May;10(3):690-698. doi: 10.1111/jdi.12949. Epub 2018 Oct 30.

Abstract

Aims/introduction: To evaluate the contribution of pancreatic α-cell function to the dawn phenomenon, insulin sensitivity, hepatic glucose uptake and glycemic variability in patients with type 1 diabetes.

Materials and methods: In 40 patients with type 1 diabetes, arginine stimulation tests were carried out, and the area under the curve (AUC) of glucagon was measured using radioimmunoassays (AUCglc RIA ) and enzyme-linked immunosorbent assays (AUCglc ELISA ). The ratio of the insulin dose delivered by an artificial pancreas to maintain euglycemia between 04.00 and 08.00 hours or between 00.00 and 04.00 hours was measured as the dawn index. The glucose infusion rate and hepatic glucose uptake were measured using hyperinsulinemic euglycemic clamp and clamp oral glucose loading tests. Glycemic variability in 96 h was measured by continuous glucose monitoring.

Results: The median dawn index (1.7, interquartile range 1.0-2.8) was not correlated with AUCglc RIA (R2 = 0.03, P = 0.39) or AUCglc ELISA (R2 = 0.04, P = 0.32). The median glucose infusion rate (7.3 mg/kg/min, interquartile range 6.4-9.2 mg/kg/min) was significantly correlated with AUCglc RIA (R2 = 0.20, P = 0.02) and AUCglc ELISA (R2 = 0.21, P = 0.02). The median hepatic glucose uptake (65.3%, interquartile range 40.0-87.3%) was not correlated with AUCglc RIA (R2 = 0.07, P = 0.26) or AUCglc ELISA (R2 = 0.26, P = 0.79). The standard deviation of glucose levels measured by continuous glucose monitoring was significantly correlated with AUCglc RIA (R2 = 0.11, P = 0.049), but not with AUCglc ELISA (R2 = 0.01, P = 0.75).

Conclusions: Pancreatic α-cell function contributed to insulin sensitivity in patients with type 1 diabetes.

Keywords: Insulin sensitivity; Pancreatic α-cell; Type 1 diabetes.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers / analysis
  • Blood Glucose / analysis
  • Blood Glucose Self-Monitoring / methods*
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 1 / pathology
  • Female
  • Follow-Up Studies
  • Glucagon / metabolism
  • Glucagon-Secreting Cells / drug effects*
  • Glucagon-Secreting Cells / metabolism
  • Glucagon-Secreting Cells / pathology
  • Glucose Clamp Technique
  • Glucose Tolerance Test
  • Glycated Hemoglobin / analysis
  • Humans
  • Hyperglycemia / epidemiology*
  • Hyperinsulinism / epidemiology*
  • Hypoglycemic Agents / pharmacology
  • Incidence
  • Insulin / pharmacology*
  • Insulin Resistance*
  • Male
  • Middle Aged
  • Prognosis

Substances

  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • hemoglobin A1c protein, human
  • Glucagon